Positive phase III results for odevixibat for progressive familial intrahepatic cholestasis

Nat Rev Gastroenterol Hepatol. 2022 Sep;19(9):556. doi: 10.1038/s41575-022-00667-x.
No abstract available

Publication types

  • Clinical Trial, Phase III

MeSH terms

  • Benzodiazepines* / therapeutic use
  • Butyrates* / therapeutic use
  • Cholestasis, Intrahepatic* / drug therapy
  • Humans

Substances

  • Butyrates
  • Benzodiazepines
  • odevixibat

Supplementary concepts

  • Cholestasis, progressive familial intrahepatic 1